With a price-to-sales (or "P/S") ratio of 1.2x Avillion Berhad (KLSE:AVI) may be sending bullish signals at the moment, given that almost half of all the Hospitality companies in Malaysia have P/S ...
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, ...
LONDON, Sept. 5, 2019 /PRNewswire/ -- Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory ...
Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysis Phase IIIb clinical development of Airsupra was conducted by Avillion under an ...
Merck KGaA is partnering Phase II and Phase III development of its therapeutic anti-interleukin-17 (IL-17) A/F Nanobody ® (M1095; ALX-0761) for treating plaque psoriasis, with Avillion, a U.K.-based ...
Avillion LLP, which focuses on clinical co-development of therapeutics, today announced the expansion of its leadership team with the appointment of Ramani Varanasi, MSc, MBA, as Chief Business ...
UK biotech Avillion has reported positive mid-stage results with chronic psoriasis drug sonelokimab, which it is developing with Merck KGaA as an alternative to drugs like Novartis' Cosentyx. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results